Chimeric antigen receptor–T cell therapy—already approved for some cancers—might help human patients with the autoimmune disorder.
Read more
Chimeric antigen receptor–T cell therapy—already approved for some cancers—might help human patients with the autoimmune disorder.
Comments are closed.